The Australian-based biotech company is developing peptide therapeutics to treat neurodegenerative conditions.
NeuroScientific Biopharmaceuticals taking a different approach to treat Alzheimer's Disease
Quick facts: NeuroScientific Biopharmaceuticals Ltd
Price: 0.185 AUD
Market Cap: $14.5 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE